ACTRN12622001078741已完成未知
Effect of two probiotic formulations on mental health and mood biomarkers in adults with depressive symptoms: A pilot randomized placebo-controlled trial.
Clinical Research Australia0 个研究点目标入组 62 人开始时间: 2022年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1.Generally healthy adults (male and female) 18 to 65 years
- •2.Currently experience mild to moderate depressive symptoms as indicated by a score of between 20 and 40 on the BDI-II at both the screening and baseline visit
- •3.Body mass index (BMI) between 18.5 and 30.0 kg/m2
- •4.Non-smoker
- •5.No plan to change dietary or exercise habits during the study period
- •6.No recent history (within 3 months) or plan to commence new treatments over the study period
- •7.Willing and able to take probiotic/placebo regimen for 12 weeks
- •8.Understand, willing and able to comply with all study procedures
- •9.Willing to provide a personally signed and dated informed consent form detailing all pertinent aspects of the trial.
排除标准
- •1.Suffering from recently diagnosed or unmanaged medical conditions including but not limited to: diabetes, hyper/hypotension, cardiovascular disease, a gastrointestinal disease requiring regular use of medications, gallbladder disease, autoimmune disease, endocrine disease, acute or chronic pain condition, or cancer/malignancy
- •2.Diagnosis of psychiatric or neurological conditions including but not limited to: psychiatric disorders other than mild-to-moderate depression and/or anxiety disorder, or neurological disease (e.g., Parkinson’s, Alzheimer’s disease, intracranial hemorrhage, head or brain injury)
- •3.Regular medication intake, including but not limited to anticholinergics, anti-epileptics, acetylcholinesterase inhibitors, benzodiazepines, antipsychotics, opioids, or corticosteroids.
- •4.Within 2 months before screening, the use of pharmaceutical medications, including but not limited to immunosuppressant drugs, antibiotics, and steroids
- •5.Change in medication (dose or type) in the last 3 months or an expectation to change during the study duration. Permitted medications include, but are not limited to, pharmaceutical antidepressants such as selective serotonin reuptake inhibitors (SSRIs), and serotonin and norepinephrine reuptake inhibitors (SNRIs), cholesterol-lowering medications, antihypertensives, proton pump inhibitors, and thyroid medications,
- •6.Use of probiotics or mood support supplement up to 4 weeks before study commencement
- •7.Current or 12-month history of illicit drug abuse
- •8.Alcohol intake greater than 14 standard drinks per week
- •9.Any significant surgeries over the last year
- •10.Women who are pregnant, breastfeeding or intend to fall pregnant
研究者
相似试验
已完成
不适用
Effect of Two Probiotic Formulations on Mental Health and Mood Biomarkers in Adults With Depressive SymptomsDepression, AnxietyNCT05564767Chr Hansen62
已完成
不适用
Effects of probiotics on cognition and mood status in community-dwelling elderlyKCT0003929Seoul National University96
已完成
2 期
The Effect of Probiotics on Mental HealthHealthy persons exposed to petrochemical pollutants..Occupational exposure to toxic agents in other industriesIRCT201406222394N11Petrochemical Research & Technology Co.+ Vice Chancellor of Research, Iran University of Medical Sc35
已完成
2 期
Impact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video GamersStressAttention DisturbancesNCT05545813Lallemand Health Solutions36
已完成
不适用
Probiotics and wellbeing in adults with type 1 diabetestype 1 diabetesdepressionstressMental Health - DepressionanxietyMental Health - AnxietyMetabolic and Endocrine - DiabetesACTRN12620000294954The University of Auckland74